Stay Long VirnetX In 2013 Despite The Trial With Cisco [View article]
Any thoughts on the supposed fact (as I've read other posts elsewhere) that VHC has never commercialized any of their technologies....does this pose a potential problem?
Wow, this drug, Kevetrin could very well become the de facto drug of choice for almost all cancers."Please add a little Special K to the cancer cocktail Doc." Man, I pray this stuff pans out! CTIX at 2 bucks a share seems to be a tremendous speculation. Why don't we call it the "wealth and health company!"
Why The Aspire Deal Is A Winner For Cellceutix Shareholders [View article]
Nice write up Karen. Understanding that financing arrangement is key and you did a wonderful job explaining it vs, a bad financing deal. Now we need some more eyes and some biomarker news!
Raja...can't argue against you. But even if the pps goes to 2-3 cents via a pp or whatever, I can only say, "don't look a gift horse in the mouth." I concur with your enthusiasm on the science. At this stage, the pps can easily drop 30-50% or it could go up the same. We can only regret our poor timing having gotten in at much higher prices, but hopefully "the spring is being compressed."
We know the a/s is now 1billion shares so evn if they get to that number in the o/s, at .05, that is only a market cap of $50million. If this stuff works, there's no reason to think that this couldn't trade at a mc of $200-300million on proof of concept.....which would be a sweet 4-5 bagger. Looks bad now from the pps and financials, but this is the time to buy your straw hats. JMHO.
Volatile VirnetX (VHC -5.9%) is heading lower. Yesterday, SA's Value Bulldog (formerly Special K) provided the second part of a bearish report on the IP holder (previous). Among the author's arguments: VirnetX efforts to have its 4G patents declared standards-essential remain in limbo; the company is unlikely to collect a 1% royalty on 4G phone sales, as some hope; and the company appears richly valued relative to fellow mobile patent holder InterDigital. [View news story]
And his lame report was slapped down OH SO EASILY by floydrocks.
VirnetX: Do You Believe In Fairytales? Part 2 [View article]
Hey Valueless Bullsheet, answer the Qs from Floydrocks if you have any. Per your profile, I'm sure you did your shorty job well with your shallow DD. Wishing you continued success...not.
Top 10 Reasons Star Scientific Is Headed Higher [View article]
Called my local GNC store here in Raleigh and was told that they were out and that no store within a 50 miles radius of Raleigh had Anatabloc in stock....so I ordered directly from the company under the auto reorder set up...every 30 days with no shipping charges, cost $79.99. Will start taking as soon as I get it in 3-4days($4.95) and will be anxious to see what my C-reacitve protien level will be compard to prior. Will only have had 5-6 days of taking the stuff when I go in for my yearly physical and bloodwork.
New Drug from Sunshine Biopharma, Inc. (SBFM) to Play Critical Role in Fight against Cancer [View instapost]
Preclinical studies are basically completed...believe we'll see P1 beginning by Q4 or soon thereafter. Their drug could be one of the major breakthroughs in cancer treatment...and right now the stock is dirt cheap. Problem here looks to be the B/S...no cash at the moment....so one has to assume we'll see dilution. CEO/Advamonics owns 70% of the stock....float is only 8.5MM....
SBFM Share Structure Verified With CFO Camille Sebaaly via Post #1020 On 12/27/11
Authorized --- 200 M Outstanding ~ 48.4 M Float ~ 8.5 M
Stay Long VirnetX In 2013 Despite The Trial With Cisco [View article]
An Interview With Leo Ehrlich, Cellceutix CEO [View article]
Is Senesco Technologies The Next Cellceutix? [View article]
The Amazing P53 Race [View article]
Why The Aspire Deal Is A Winner For Cellceutix Shareholders [View article]
Smooth
Global Warming Will Push Gold Higher [View article]
Advaxis, Inc. (ADXS) Is “One To Watch” [View instapost]
Advaxis, Inc. (ADXS) Is “One To Watch” [View instapost]
Volatile VirnetX (VHC -5.9%) is heading lower. Yesterday, SA's Value Bulldog (formerly Special K) provided the second part of a bearish report on the IP holder (previous). Among the author's arguments: VirnetX efforts to have its 4G patents declared standards-essential remain in limbo; the company is unlikely to collect a 1% royalty on 4G phone sales, as some hope; and the company appears richly valued relative to fellow mobile patent holder InterDigital. [View news story]
VirnetX: Do You Believe In Fairytales? Part 2 [View article]
Top 10 Reasons Star Scientific Is Headed Higher [View article]
New Drug from Sunshine Biopharma, Inc. (SBFM) to Play Critical Role in Fight against Cancer [View instapost]
SBFM Share Structure Verified With CFO Camille Sebaaly via Post #1020 On 12/27/11
Authorized --- 200 M
Outstanding ~ 48.4 M
Float ~ 8.5 M
Insiders Owned & Restricted ~ 39.9 M